Retina

Josh  Anderson, head of U.S. retina sales and marketing for Alcon, outlines what attendees will learn including product updates, new technologies, and practice management materials for ophthalmologists and their patients during the COVID-19 pandemic.

Prof. Giovanni Staurenghi, chairman of the University Eye Clinic, Department of Biomedical and Clinical Sciences at the University of Milan’s Luigi Sacco Hospital, Italy, discusses his presentation from this year's AAO, including findings from the HARBOR study of macular atrophy in AMD patients treated with ranibizumab.

During Day 1 of AAO 2020, Carl Awh, MD, discusses the Micro-Vacuum Pick, a device for peeling internal limiting membranes that's providing vitreoretinal surgeons an alternative to forceps during surgeries.

At AAO 2020, Fernando Arevalo, MD, PhD, details the use of anti-VEGF therapy for the treatment of retinal arteriolar macroaneurysms that are near the fovea.

DME diagnosis plays no role in determining whether patients will receive injection.

Device allows visually impaired to recognize shapes, distinguish between light and dark.

The program is dedicated to the education of fellows and residents and offers a unique opportunity to share notable retina research with peers and mentors.

Watchful waiting may prove to be beneficial in complicated cases

Dilation may be an important step to reduce the rate of ungradable images

This ability would unlock possibilities for repairing tissue damaged by disease

Investigators have found that the diameter of retinal veins may be linked directly to the severity of COVID-19. Assessing the retinal veins may be a part of diagnosing and managing the disease.

Study points to possible role of addressing preprocedural anxiety

In study, treatment demonstrates promising biologic activity, safety profile

High-quality images can be useful for early diagnosis, prognosis, monitoring

Patients underwent short-course, perioperative systemic immunosuppression prior to procedure

Investigators find that nanoparticles deliver gene therapy successfully in mice, rats.

Pandemic highlights need for longer-lasting agents to reduce treatment burden in evolving field.

Investigators find value in screening for macular disease in preoperative evaluation

S.K. Steven Houston III, MD, shares how his practice has put to use recent retina innovations and adapted to accommodate the ever-changing operating room spacing and set-up in the current COVID-19 environment.

Megan Berkenstock, MD, assistant professor of ophthalmology at the Wilmer Eye Institute (Johns Hopkins University) speaks on the change in patient diagnoses and visit numbers by subspecialties in the weeks before and after the discovery of COVID-19 as well as the protocol needed to allow for the program's ambulatory surgery centers.

Pandemic is disrupting clinical facilities, putting individuals’ ocular health at risk

Ophthalmologists share what keeps them up at night in the ophthalmic profession amid the pandemic.

Research results can help ophthalmologists treating patients with macular edema

Investigators examine and analyze outcomes of aflibercept compared with laser treatment in patients

Ophthalmologists share their outlook for the current state and future of the ophthalmic profession, how coronavirus pandemic has altered the profession as well as how —now, more than ever — patient care remains a number one priority for ophthalmologists.